WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Stock Ownership - Who owns Eyepoint Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Eyepoint Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jay S. DukerPresident and CEO2025-07-107,688$11.06
$85.03kSell
Jay S. DukerPresident and CEO2025-06-2356,665$8.21
$465.22kSell
George ElstonChief Financial Officer2025-05-252,202$5.68
$12.51kSell
Karen L. ZaderejDirector2025-05-195,000$5.99
$29.95kBuy
Karen L. ZaderejDirector2025-05-165,000$5.81
$29.05kBuy
Karen L. ZaderejDirector2025-05-155,000$5.47
$27.35kBuy
Karen L. ZaderejDirector2025-05-145,000$5.42
$27.10kBuy
Jay S. DukerPresident and CEO2025-03-1920,000$6.16
$123.10kSell
Jay S. DukerPresident and CEO2025-02-092,055$6.50
$13.35kSell
Jay S. DukerPresident and CEO2025-01-066,108$8.68
$53.02kSell

1 of 2

EYPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EYPT insiders and whales buy or sell their stock.

EYPT Shareholders

What type of owners hold Eyepoint Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ew Healthcare Partners LP126.87%87,298,833$1.02BInsider
Pfizer Inc108.24%74,483,748$873.69MInsider
Ronald W. Eastman25.01%17,212,648$201.90MInsider
Cormorant Asset Management LP17.23%11,855,943$139.07MInsider
Cormorant Asset Management LP12.10%8,325,000$97.65MInstitution
Suvretta Capital Management LLC9.89%6,804,091$79.81MInstitution
Adage Capital Partners GP LLC9.88%6,800,000$79.76MInstitution
Blackrock Inc7.79%5,360,214$62.88MInstitution
Adage Capital Management LP7.49%5,156,299$60.48MInsider
Federated Hermes Inc6.68%4,599,450$53.95MInstitution

1 of 3

EYPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EYPT25.81%74.19%Net Selling
AVBP76.19%23.81%Net Buying
TYRA62.08%37.92%Net BuyingNet Buying
KOD67.70%32.30%Net Selling
GERN80.63%1.09%Net BuyingNet Buying
View Top Biotech Stocks

Eyepoint Pharmaceuticals Stock Ownership FAQ

Who owns Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ: EYPT) is owned by 100.15% institutional shareholders, 287.87% Eyepoint Pharmaceuticals insiders, and 0.00% retail investors. Ew Healthcare Partners LP is the largest individual Eyepoint Pharmaceuticals shareholder, owning 87.30M shares representing 126.87% of the company. Ew Healthcare Partners LP's Eyepoint Pharmaceuticals shares are currently valued at $1.01B.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.